The Association of Human Leukocyte Antigens Complex with Type 1 Diabetes in the Omani Population
Overview
Authors
Affiliations
Objectives: Identification of the high risk alleles, genotypes and haplotypes of the human leukocyte antigens (HLA) in different populations is beneficial for understanding their roles in type 1 diabetes (T1D) pathogenesis and intervention practices. This study aimed to identify T1D-associated HLA gene alleles in the Omani population.
Methods: The present case-control study included 73 diabetic seropositive children (mean age 9.08 ± 3.27 years) attending the paediatric clinic at Sultan Qaboos University Hospital in Muscat, Oman, and 110 healthy controls. , , , and genes were genotyped using a sequence-specific primer polymerase chain reaction (SSP-PCR).
Results: Two HLA class I alleles (, ) and three class II alleles (, and ) were associated with T1D susceptibility, while one class I () and three class II (, and ) alleles were associated with T1D protection. and alleles showed the strongest risk association among all alleles. Six residues (E, S, S, Y, V and K) were significantly associated with T1D susceptibility. Heterozygous genotypes, / and / were significantly associated with T1D susceptibility ( <0.0001, odds ratio [OR] = 63.21 and = 0.02, OR = 3.63, respectively). Furthermore, a significant combined action of - haplotype in T1D risk ( = 0.000176, OR = 15) and - haplotype in protection ( = 0.0312, OR = 0.48) was detected.
Conclusion: Known HLA class II gene alleles are associated with T1D in Omani children.
Noble J Front Immunol. 2024; 15:1457213.
PMID: 39328411 PMC: 11424550. DOI: 10.3389/fimmu.2024.1457213.
Al-Shamahy H, Abdo Hassan S Oman Med J. 2024; 39(1):e590.
PMID: 39006310 PMC: 11246548. DOI: 10.5001/omj.2024.46.
Genetic and Epigenetic Aspects of Type 1 Diabetes Mellitus: Modern View on the Problem.
Minniakhmetov I, Yalaev B, Khusainova R, Bondarenko E, Melnichenko G, Dedov I Biomedicines. 2024; 12(2).
PMID: 38398001 PMC: 10886892. DOI: 10.3390/biomedicines12020399.
Noble J, Besancon S, Sidibe A, Rozemuller E, Rijkers M, Dadkhodaie F HLA. 2024; 103(1):e15319.
PMID: 38226399 PMC: 10863981. DOI: 10.1111/tan.15319.
Dashti M, Nizam R, Jacob S, Al-Kandari H, Al Ozairi E, Thanaraj T Front Immunol. 2023; 14:1238269.
PMID: 37638053 PMC: 10457110. DOI: 10.3389/fimmu.2023.1238269.